Use of systemic therapies for psoriasis in the COVID-19 era.

Donovan G KearnsShelley UppalVipawee S Chat Jashin J Wu

Published in: The Journal of dermatological treatment (2021)

Patients with active COVID-19 infections should discontinue systemic treatment for psoriasis. Patients with risk factors should discuss continuing treatment on a case by case basis.

Keyphrases

coronavirus disease
sars cov
risk factors
atopic dermatitis
replacement therapy